PONIARD PHARMACEUTICALS, INC. Inactive Instrument
Poniard Pharmaceuticals, Inc. Stock Other OTC
Equities
PARD
US7324494001
Pharmaceuticals
Financials (USD)
| Sales 2009 | - | Sales 2010 | - | Capitalization | 25.13M |
|---|---|---|---|---|---|
| Net income 2009 | -45M | Net income 2010 | -30M | EV / Sales 2009 | - |
| Net cash position 2009 | 23.12M | Net cash position 2010 | 2.76M | EV / Sales 2010 | - |
| P/E ratio 2009 |
-1.4
x | P/E ratio 2010 |
-0.79
x | Employees | - |
| Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 2.5% |
More Fundamentals
* Assessed data
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -5.99% | 84.46B | |
| +3.95% | 40.85B | |
| -26.37% | 27.69B | |
| +52.34% | 24.28B | |
| -6.59% | 17.09B | |
| -32.37% | 13.67B | |
| -10.45% | 11.79B | |
| -15.88% | 11.86B | |
| -2.85% | 8.07B |
